- Home
- PAYC vs PCVX Comparison
PAYC vs PCVX Comparison
Compare PAYC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYC
- PCVX
- Stock Information
- Founded
- PAYC 1998
- PCVX 2013
- Country
- PAYC United States
- PCVX United States
- Employees
- PAYC N/A
- PCVX N/A
- Industry
- PAYC Computer Software: Prepackaged Software
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- PAYC Technology
- PCVX Health Care
- Exchange
- PAYC Nasdaq
- PCVX Nasdaq
- Market Cap
- PAYC 14.6B
- PCVX 4.4B
- IPO Year
- PAYC 2014
- PCVX 2020
- Fundamental
- Price
- PAYC $224.07
- PCVX $35.76
- Analyst Decision
- PAYC Hold
- PCVX Strong Buy
- Analyst Count
- PAYC 11
- PCVX 10
- Target Price
- PAYC $230.00
- PCVX $136.50
- AVG Volume (30 Days)
- PAYC 647.3K
- PCVX 1.5M
- Earning Date
- PAYC 07-30-2025
- PCVX 08-05-2025
- Dividend Yield
- PAYC 0.68%
- PCVX N/A
- EPS Growth
- PAYC N/A
- PCVX N/A
- EPS
- PAYC 7.02
- PCVX N/A
- Revenue
- PAYC $1,913,800,000.00
- PCVX N/A
- Revenue This Year
- PAYC $10.03
- PCVX N/A
- Revenue Next Year
- PAYC $9.22
- PCVX N/A
- P/E Ratio
- PAYC $31.35
- PCVX N/A
- Revenue Growth
- PAYC 9.87
- PCVX N/A
- 52 Week Low
- PAYC $140.69
- PCVX $27.66
- 52 Week High
- PAYC $267.76
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- PAYC 35.90
- PCVX 57.77
- Support Level
- PAYC $222.20
- PCVX $31.79
- Resistance Level
- PAYC $236.24
- PCVX $36.89
- Average True Range (ATR)
- PAYC 6.25
- PCVX 1.51
- MACD
- PAYC -0.21
- PCVX 0.37
- Stochastic Oscillator
- PAYC 19.35
- PCVX 77.65
About PAYC Paycom Software Inc.
Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.